Showing posts with label herbal medicine. Show all posts
Showing posts with label herbal medicine. Show all posts

India Grants Access to U.S. Patent Examiners for New Traditional Knowledge Search Tool

Thursday, November 26, 2009


WASHINGTON – The Commerce Department’s United States Patent and Trademark Office (USPTO)  today announced that the Government of India has granted the agency’s patent examiners access to a new digital database containing a compilation of traditional Indian knowledge. Access to the Traditional Knowledge Digital Library (TKDL) is important for both India and the United States to prevent misappropriation of traditional knowledge.

“The USPTO has long been concerned about attempts to patent traditional knowledge, not only because it may result in an incorrectly granted patent, but also because it removes knowledge from the public domain,” said Sharon Barner, Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO.

This database will be an important addition to the growing array of search tools on traditional knowledge from around the world that is already available to USPTO examiners. These tools include dictionaries, formularies, handbooks, and historical or classical works, as well as databases such as the TKDL. USPTO examiners use these tools to help prevent the patenting, and thereby misappropriation, of existing traditional knowledge. A listing of some of these publicly available traditional knowledge tools can be found on the USPTO’s Web site at: http://www.uspto.gov/web/offices/dcom/olia/tradknowledge.html.

“We have urged countries to create, and make available to examiners around the world, digital libraries of their traditional knowledge to prevent erroneous patent grants,” Barner said. “India’s TKDL is just such a library, and we are pleased that our examiners now have access to it.”

The new database, developed jointly by India’s Council of Scientific & Industrial Research (CSIR) and the Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy (AYUSH), includes over 200,000 traditional medicine formulations on Ayurveda, Unani and Siddha comprising 30 million pages. The TKDL contains text-searchable English-language translations of these sources, permitting USPTO examiners to search thousands of years of India’s accumulated traditional knowledge. The TKDL also contains translations into French, German, Japanese and Spanish, from these sources, originally written in Hindi, Sanskrit, Arabic, Persian and Urdu.

The misappropriation of traditional knowledge through the mistaken issuance of patents has been a growing concern with the rise of the global economy and the increasing importance of intellectual property. A few high profile cases brought significant attention to this matter, prompting efforts by a number of countries to create digital traditional knowledge databases accessible to patent examiners around the world. If a patent application attempts to claim an invention within the existing traditional knowledge, a patent examiner will reject the application provided they can find evidence proving the prior existence of that knowledge. Searching the TKDL will provide access to just the sort of evidence needed by examiners to establish that proof.

Source: US Patent and Trademark Office - Official Press Release

AYUSH to take home remedies out to market

Monday, November 23, 2009

Aditya Dev, TNN 23 November 2009, 05:06am IST


CHANDIGARH: The department of ayurveda, yoga and naturopathy, unani, siddha and homoeopathy (AYUSH) is planning to put ‘trusted’ home remedies preached and practised by grannies in many households in the ‘tested’ category. The effort is intended as a way to get rid of present generation’s pill fixation.

AYUSH will invite people to tell it about the methods they use at home. If those are found effective in subsequent trials, the department will try to get the person forwarding it, the method’s patent and also devise ways to market the idea.

More importantly, any individual or institution can be part of this extramural research system.

Department’s officials said this was being done as India’s share in the global market was negligible when it came to traditional medicines. They stated that AYUSH also wanted to develop products having intellectual property rights (IPR) potential, which might lead to increase in exports.

Amarjeet Singh of PGI School of Public Health said, ‘The good thing is that this system is open to the public.’

His department has been in talks regarding at least three projects with AYUSH.

The projects are connected with efficacy of neem oil as mosquito repellent, use of ginger and garlic as cough syrup and developing exercises to control the problem of incontinence in women.

He added that preliminary drafts of the projects had been sent to AYUSH and discussions were in advance stage. ‘Going to the roots of alternative medical systems can prove a safe bet in the global market. It can also help people in avoiding hospital visits for simple ailments and make treatment available with minimum side effects,’ he mentioned.

All welcome

People participating in this system of extra mural research can range from eminent scholars to lay persons. Universities and educational institutions can also take part in it. The patent will be jointly applied for by the concerned research council working under AYUSH and the person who brings the method to it for verification.

Source: Times Of India

Ayurvedic Metallic Preparations are Safe...!

Saturday, October 31, 2009

Dept of Ayush certifies safety of 8 bhasmas under Golden Triangle Project
Friday, October 30, 2009 08:00 IST
Nandita Vijay, Bangalore


The department of Ayush has certified 8 bhasmas to be safe for use and the details will be will be released in December. This validation of 8 bhasmas is the maiden project under the Golden Triangle project of the Central government. The project, set up with the support of the department of Ayush Indian Council of Medical Research (ICMR) and Council of Scientific and Industrial Research (CSIR), is expected to scientifically validate Ayurveda products.

The standardization, safety and toxicity studies of metallic bhasmas and mineral-based formulations including Kupipakwa Rasayanas have been a major issue for a while for the drug manufacturers, according to JSD Pani, president, Karnataka Indian Medicine Manufacturers Association. The issue of the presence of minerals and heavy metals has bogged down international marketing operations. Therefore the effort by the Ayush department will now help the industry, he added.

The Planning Commission had constituted a Working Group on Access to Health Systems in Ayush which in-turn formed five Sub-Group and one of them focused only on the standardization and Quality Control of Ayush drugs.


The Ayush department was keen to lay down pharmacopoeial standards for single and compound formulations besides carry out scientific validation of herbo-metallic compounds and address the standardization and quality control of herbal drugs. There is also a proposal to set up a Pharmacopoeial Commission for Indian Medicine under the 11th Plan which will be located in the newly constructed building of the Pharmacopoeial Laboratory of Indian Medicine, Ghaziabad. The key objective is to create an independent scientific body which will undertake laying down of pharmacopoeial standards and its revision.

The Department is likely to enforce mandatory testing of heavy metals not only for export of Ayurveda, Siddha and Unani medicines but also for sale in domestic market. Since over 80 per cent of the Ayush manufacturing units are in the small and medium scale sector, the department identified labs to test the drugs for these companies. This is because equipments like Atomic Absorption Spectrometer to test heavy metals and TLC/HPTLC/GLC to test crude drugs are expensive to be installed by many companies to test the raw materials and finished products.

Pani said that these metals have undergone extensive toxicity studies. There had been no reports of major adverse drug reaction. Standardization and quality control of Ayurveda, Siddha, Unani drugs is a problem area as botanicals do not lend themselves to as precise a quality control as synthetic molecules manufactured under controlled laboratory conditions. This requires state-of-the-art research for developing chemical/biological markers/chromatogram fingerprints/standardized operating procedures and phyto-chemical characterization of bhasmas.

Now with the department of Ayush being ready with the safety data of the 8 bhasmas, this would provide a major fillip for growth for the Traditional System of Medicine industry, stated Dr GG Gangadharan, joint director (Traditional System of Medicine), Foundation for Revitalization of Local Health Traditions (FRLHT).

Source: PharmaBiz